Haoxi's Reverse Split Redux: A Nasdaq Lifeline or a Sign of Distress?

BEIJING, China – August 12, 2026 – Haoxi Health Technology Limited (NASDAQ: HAO) today announced it will perform a 1-for-20 reverse share split, a significant corporate maneuver that will take effect at the market's opening on August 14. For the Beijing-based online marketing firm, this is not an unfamiliar move. It marks the company's second such action in just three months, raising critical questions about its financial stability and long-term strategy to remain on a major U.S. exchange.

The announcement itself was straightforward: consolidate every twenty shares into one, artificially boosting the per-share price from its current level of around $0.16. The goal is clear, but the implications are complex. While management frames these actions as necessary housekeeping, a closer look reveals a company caught between a desperate fight for Nasdaq compliance and an ambitious pivot towards artificial intelligence in the booming Chinese healthcare market.

A Race Against Delisting

At the heart of Haoxi's repeated reverse splits is a battle against the clock imposed by The Nasdaq Stock Market. The exchange mandates that a company's stock maintain a minimum bid price of $1.00 per share. Falling below this threshold for 30 consecutive business days triggers a deficiency notice and starts a countdown to potential delisting.

Haoxi is intimately familiar with this process. The company's share price has been under immense pressure, and this 1-for-20 split comes on the heels of a much larger 1-for-128 reverse split executed just this past May. At that time, shares were trading at a mere $0.02, having collapsed by nearly 99% over the preceding year. The May split was intended to solve the Nasdaq compliance issue, but the relief was short-lived as the newly adjusted share price failed to hold its ground, quickly eroding back below the critical $1.00 mark.

This second attempt in such a short period raises the stakes considerably. Nasdaq has implemented stricter rules for companies that repeatedly use reverse splits to regain compliance. If a stock price again falls below the minimum threshold within a year of a split, the exchange may not grant another compliance period, potentially leading to immediate delisting proceedings. For Haoxi, this 1-for-20 split is not just a strategic option; it's a high-stakes necessity with a narrowing margin for error.

Unpacking the Financials: A Tale of Contradictions

While a reverse split is a financial engineering tool, it does not alter a company's underlying value or solve its operational challenges. An examination of Haoxi's financial performance reveals a complex and somewhat contradictory picture that helps explain the market's skepticism. The company, which provides online short video marketing solutions for healthcare clients in China, operates in a high-growth sector. Yet, its own performance has been volatile.

For its 2025 fiscal year, Haoxi reported a sharp 32% decrease in revenue to $32.8 million. Curiously, net income for the same period was reported to have increased by 200% to $3.9 million. However, more recent filings paint a gloomier picture. The latest quarterly results show a net loss of $6.88 million, and the company's operating cash flow has turned negative, indicating it is burning through cash to sustain its operations. This cash burn is further evidenced by a series of capital raises, including a $4 million registered direct offering in July and a $6.5 million offering in May. These moves, while providing necessary liquidity, dilute existing shareholders and signal an urgent need for funds.

This financial turbulence is the root cause of the stock's decline. Investors are weighing the potential of the Chinese digital health market against the firm's declining revenue and cash-flow challenges. The reverse split, in this context, is seen by many as a cosmetic fix that fails to address the fundamental business issues.

The AI Pivot Amidst Market Turmoil

Contrasting with the narrative of financial struggle is Haoxi's aggressive push into artificial intelligence. The company is not sitting idle; it's actively forging partnerships to reposition itself as a tech-forward player. In July, it announced a strategic cooperation with NOVA MEDIA to develop an AI-powered digital marketing system. This followed a March announcement of a partnership with Eaglepoint AI to enter the AI-powered health management sector.

These initiatives are strategically sound. The Chinese online healthcare market is projected to become a nearly $600 billion industry by 2028, with AI-enabled services for chronic disease management and online diagnostics being major drivers. By investing in AI, Haoxi is attempting to align itself with these powerful market trends and create a new narrative for growth that extends beyond its current marketing services.

The question for investors is whether this strategic pivot can bear fruit before the company's financial runway runs out. The reverse splits can be interpreted as a tactic to buy time—time to stay listed, time to attract new capital, and time for its AI bets to pay off. It’s a race to build a more valuable future while the present remains precarious.

Investor Fatigue and the 'Reverse Split' Signal

The market's reaction to Haoxi's latest move has been predictably negative. Following the announcement, the stock fell over 3%, continuing a pattern of investor disapproval. The reaction to its May split was even more severe, with the stock plunging over 20%. For seasoned market watchers, this is no surprise. A reverse stock split, especially a second one in quick succession, is often interpreted as a major red flag.

"It's a signal of weakness, not strength," commented one corporate finance analyst, speaking on background. "Fundamentally, you're not creating any new value. You're just giving shareholders one share worth $3.20 instead of twenty shares worth $0.16 each. The market knows this and often punishes the stock because it confirms that the company can't achieve a healthy share price through operational success alone." This sentiment is a key reason why many reverse splits are followed by continued downward pressure on the stock.

For Haoxi's shareholders, the move consolidates their holdings but does little to assuage fears about the company's trajectory. While management hopes to attract a new class of institutional investors who may be prohibited from holding penny stocks, the persistent use of this financial tool has created a clear pattern of investor fatigue and skepticism.